在静态体外消化过程中,哪些因素会影响乳制品和植物性产品中的生物可访问性?
Rozenn Le Foll1, Frédéric Gaucheron2, Corinne Marmonier2
1INRAE, Institut Agro, STLO, 35042 Rennes, France.
Food research international (Ottawa, Ont.)
|January 9, 2026
概括
饮食中的溶性和生物可访问性在不同食物来源之间有很大差异. 乳制品提供较高的生物可用与植物替代品相比,受食品成分在消化过程中相互作用的影响.
科学领域:
- 营养科学 营养科学
- 食品化学 食品化学
- 胃肠病学 胃肠病学
背景情况:
- 缺乏是全球性的健康问题.
- 乳制品是西方饮食中主要的来源,但植物性食物也会有所贡献.
- 了解来自不同食物矩阵的生物可用性对于公众健康至关重要.
研究的目的:
- 从各种食物来源量化的溶解性和生物可访问性.
- 研究特定食品成分对生物可用性的影响.
- 为了比较乳制品和植物性食品选择之间的生物可用性.
主要方法:
- 使用了一个静态的体外胃肠道消化模型 (INFOGEST).
- 在模型溶液和真实食品样本 (乳制品和植物性) 中分析含量.
- 使用感应合的等离子光辐射光谱法测量可溶性的度.
主要成果:
- 胃阶段 (低pH值) 增强了溶解.
- 肠道阶段 (pH ~7) 降低了的溶解度,这是由于与酸盐,棕酸盐,素和植物酸盐的复杂形成.
- 乳制品显示出高生物可访问性 (1934%),而植物性食品显示出不同的结果 (127%).
结论:
- 乳制品是每份生物可访问的优质来源.
- 食品成分显著影响的溶解性和生物可用性.
- 需要进一步研究如何从植物性食品中提高的生物可用性.
相关概念视频
Protein Digestion
110.4K
Protein digestion begins in the stomach, where the highly acidic environment can easily disrupt protein structure by exposing the peptide bonds of polypeptide chains. After polypeptide chains are broken into individual amino acids by a series of digestive enzymes, the amino acids are transported to the liver via the bloodstream to produce energy.
110.4K
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
3.0K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
3.0K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
493
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
493
Factors Influencing Bioavailability: First-Pass Elimination
7.9K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
7.9K
Factors Affecting Solubility
36.6K
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Chȃtelier’s principle. Consider the dissolution of silver iodide:
36.6K
Bioavailability: Influencing Factors
331
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
331


